-
Global Zevalin Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
14 Mar 2025 15:45 GMT
… lymphoma.
• Contributing factors include the rising demand for personalized medicine … to enhance cancer treatment and patient outcomes … Lymphoma (NHL)
• By Formulation:
o In-111 Zevalin … -cancer-drugs-global-market-report
Breast Cancer Drugs Global …
-
HIRA to remove 17 drugs from Group 2 anticancer list, update reimbursement criteria
21 Feb 2025 07:53 GMT
… Group 2 anticancer drugs, deleting 17 drugs from the list … 17 cytotoxic anticancer drugs and antihormonal drugs that have been … 2 anticancer drugs list."
Ibritumomab tiuxetan (brand name: Zevalin) will … non-Hodgkin's lymphoma treatment regimen.
-
Global Zevalin Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
10 Feb 2025 23:32 GMT
… increasing government support for cancer treatment initiatives.
Get Your … zevalin market. Non-Hodgkin lymphoma, a collection of blood cancers originating in lymphocytes … ;pancreatic-cancer-drugs-global-market-report
Breast Cancer Drugs Global Market …
-
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
03 Feb 2025 18:24 GMT
… showing promise for treatment-resistant cancers, and new … startups conducting trials across various cancer types, radiopharmaceuticals … the drug product, even before a clinical trial starts … [Zevalin;Spectrum], which was approved for non-Hodgkin lymphoma …
-
Imaging the Immune System: CD8 T-Cell Tracking for Cancer and Autoimmune Disease - Anna Wu
09 Jan 2025 22:49 GMT
… immune cells, the CD8 cytotoxic lymphocytes, using this approach.
Oliver … approved products. We have clinical trials in small molecules, peptides, … to—we had Bexxar and Zevalin at one point. I… all. None of our cancer treatments are cure alls by themselves …
-
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight
16 Sep 2024 23:14 GMT
… FDA-approved follicular lymphoma drugs @ Drugs for Follicular Lymphoma Treatment
… drugs for follicular lymphoma in development @ Follicular Lymphoma Clinical Trials … Regeneron Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Xynomic Pharmaceuticals, Inc …
-
‘Really exciting times’: One biotech’s view of radiopharma’s boom
17 Sep 2024 20:28 GMT
… far as cancer treatments go, … drug field and the many smaller biotechnology … Pharmaceuticals’ Zevalin both won approvals to treat lymphoma, … pharmaceutical sciences underestimate nuclear medicine, and people in nuclear medicine underestimate pharmaceutical …
-
Human medicines European public assessment report (EPAR): Zevalin, ibritumomab tiuxetan, Date of authorisation: 16/01/2004, Revision: 23, Status: Lapsed
10 Jul 2024 14:20 GMT
… View
Product details
Name of medicine
Zevalin
Active substance
ibritumomab tiuxetan
… tiuxetan
Therapeutic area (MeSH)
Lymphoma, Follicular
Anatomical therapeutic chemical ( … .
[90Y]-radiolabelled Zevalin is indicated for the treatment of adult patients …
-
CASI Pharmaceuticals
18 Dec 2023 18:02 GMT
… on commercializing innovative therapeutics and pharmaceutical products. The products include injections … and lymphomas. The EVOMELA injection is used as a conditioning treatment before … CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The …
-
90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
03 Oct 2023 06:38 GMT
… and Drug Administration (US FDA) for the treatment of … collected from electronic medical records (EMRs) … tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia. Cancer. … with small lymphocytic lymphoma (SLL): overall clinical trial experience. …